Evidence map›Paper›PMID 34841060›Full record

ArticleACS central science2021

Clinical Trial: Magnetoplasmonic ELISA for Urine-based Active Tuberculosis Detection and Anti-Tuberculosis Therapy Monitoring.

Jeonghyo Kim, Van Tan Tran, Sangjin Oh, Minji Jang, Dong Kun Lee, Jong Chul Hong, Tae Jung Park, Hwa-Jung Kim, Jaebeom Lee

Abstract read
In one paragraph

Article in ACS central science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jeonghyo KimDepartment of Chemistry, Chungnam National University, Daejeon 34134, Republic of Korea.ORCID https://orcid.org/0000-0003-3363-0714
Van Tan TranDepartment of Chemistry, Chungnam National University, Daejeon 34134, Republic of Korea.ORCID https://orcid.org/0000-0001-9566-2899
Sangjin OhDepartment of Chemistry, Chungnam National University, Daejeon 34134, Republic of Korea.
Minji JangDepartment of Cogno-Mechatronics Engineering, Pusan National University, Busan 46241, Republic of Korea.
Dong Kun LeeDepartment of Otolaryngology, Head and Neck Surgery, College of Medicine, Dong-A University, Busan 49201, Republic of Korea.
Jong Chul HongHana Otorhinolaryngology Hospital, Ulsan 44694, Republic of Korea.
Tae Jung ParkDepartment of Chemistry, Chung-Ang University, Seoul 06974, Republic of Korea.ORCID https://orcid.org/0000-0001-8918-0957
Hwa-Jung KimDepartment of Microbiology and Medical Science, College of Medicine, Chungnam National University, Daejeon 35015, Republic of Korea.
Jaebeom LeeDepartment of Chemistry, Chungnam National University, Daejeon 34134, Republic of Korea.ORCID https://orcid.org/0000-0002-4563-2883

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The coronavirus disease 2019 (COVID-19) pandemic has proved the importance of fast and widespread diagnostic testing to prevent serious epidemics timely. The first-line weapon against rapidly transmitted disease is a quick and massive screening test to isolate patients immediately, preventing dissemination. Here, we described magnetoplasmonic nanozymes (MagPlas NZs), i.e., hierarchically coassembled Fe

Identifiers

PMID34841060
PMCPMC8614099

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.